Filters
Investing in the development of our people for long‑term growth
Insight, Report Case Study
Hikma launches authorised generic of Nucynta® ER (tapentadol) extended-release in the US
Press Release, Product
Hikma R&D. Innovation in formulation development. Meet Hamza Qassim
Story, Life at Hikma
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
Hikma launches authorised generic of Nucynta® (tapentadol) in the US
Press Release, Product
Inspired at Hikma. Meet Ana Santos Perez
Story, Life at Hikma
Building resilience in water stressed regions
Story, Responsibility
Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Story, Life at Hikma
Hikma France obtains A++ Green Index Rating for the third year running
Story, Responsibility
Hikma Jordan office achieves LEED Gold Certification for sustainable operations
Story, Responsibility
Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect...
Press Release, Product
Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
Press Release, Corporate
Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Develop...
Insight, Corporate
Delivering emergency relief through our partnership with Direct Relief
Story, Responsibility